Gallium-67 citrate imaging studies of the lung

Our plain-English summary of Gallium-67 citrate imaging studies of the lung, by C. Bekerman, P.B. Hoffer, J.D. Bitran, et al (Seminars in Nuclear Medicine, 1980).

The study

• Authors: C. Bekerman, P.B. Hoffer, J.D. Bitran, R.G. Gupta
• Journal: Seminars in Nuclear Medicine
• Published: 1980;10(3):286-301
• Type of article: Review
• Cited by: 53 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

Abstract

In spite of localization of gallium in the lungs in a large variety of inflammatory pulmonary diseases, the chest radiograph is and will continue to be the principal diagnostic tool for evaluation of pulmonary inflammatory disease. The 67Ga-citrate scan, however, serves as a study complementary to chest radiography because it indicates the extent, localization, and degree of activity of the inflammatory disease with greater accuracy than do the radiographic studies. It also permits the physician to follow progression of the disease or response to treatment and possible to detect disseminated interstitial disease not visualized on radiographs. Gallium-67 scanning may be used in the evaluation of patients with lymphorecticular neoplasms (Hodgkin's disease and malignant lymphomas) both during initial staging and in evaluation of the response to therapy. The 67Ga-citrate scan is useful in the evaluation of patients with lung cancer provided its limitations are kept in mind. It cannot and should not replace the pathologist's microscope. The scan is useful as a screening test only in patients who have radiographic lesions not consistent with inflammatory disease and in whom invasive diagnostic procedures or exploratory surgery are contraindicated unless the probability of detecting a resectable tumor is high. However, the limited resolution of the scanning system restricts the possibility of detecting lesions before they become radiographically visible. The histologic type of the lesion appears to have no effect on the probability of detection. As a noninvasive procedure, the 67Ga-citrate scan complements mediastinoscopy by indicating which lymph nodes should be biopsied. It is also useful in evaluation of the controlateral hilar node region. The scan frequently detects clinically unsuspected extrathoracic lesions. It may therefore be a useful initial procedure in guiding the work-up of the patient with a known or strongly suspected tumor. The combination of the 67Ga scan with the chest radiograph could provide the information necessary for presurgical clinical staging in patients who have no symptoms that suggest distant metastases. Gallium-67 scans may be useful in indicating the effectiveness of treatment and the sensitivity of a tumor to radiation.

In plain English

This article was a review, not a new study. The authors examined published work on gallium-67 citrate scans, a nuclear medicine imaging test, in lung disease, including inflammatory conditions, lymphoma, lung carcinoma and mesothelioma. Asbestos came up only briefly. The article noted that asbestos exposure may lead to benign or malignant pleural disease, and that clinical and X-ray studies often fail to tell benign pleural plaques, thickening and effusions apart from malignant mesothelioma. The review cited Sorek and colleagues as finding gallium scans more sensitive than chest radiographs for identifying sites of involvement in diffuse pleural mesothelioma. Those researchers also found the scan valuable for telling benign from malignant pleural disease and for monitoring asbestos-exposed populations. For pneumoconiosis, the review cited Siemsen and colleagues, who found in 25% of their cases gallium uptake more extensive than X-rays suggested. The authors concluded that, for inflammatory lung disease, the chest radiograph is and will remain the principal diagnostic tool, with the gallium scan serving as a complementary study. They noted that the scanner's limited resolution restricts detecting lesions before they become visible on X-rays.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Narrative review of published studies on gallium-67 citrate imaging of the lung
• Who was studied: No new patients were studied. The review covered published reports on patients with inflammatory lung diseases, lymphoma, lung carcinoma, diffuse pleural mesothelioma and other tumors.
• Exposure: The test under review was gallium-67 citrate scanning. Asbestos was mentioned only as a cause of benign or malignant pleural disease. No fiber types, products, jobs or doses were described.
• Main results:
  • The review stated that clinical and radiographic studies often cannot tell benign pleural plaques, thickening and effusions apart from malignant mesothelioma.
  • Cited finding (Sorek et al., not this article's own data): gallium-67 imaging was more sensitive than chest radiography in identifying sites of involvement in patients with diffuse pleural mesothelioma.
  • Cited finding (Sorek et al.): the gallium scan was described as valuable for distinguishing benign from malignant pleural disease and for monitoring asbestos-exposed populations.
  • Cited finding (Siemsen et al., pneumoconiosis): in 25% of their cases, gallium uptake was more extensive than radiographic abnormalities suggested.
  • Cited finding (Hayes and Edwards, lung carcinoma): 194 of 228 patients (85%) had positive scans.
  • Cited findings (Bekerman et al. and DeLand et al.): lung lesions smaller than 1.5 cm were undetectable on gallium scans.
• The authors' conclusion: The authors concluded that the chest radiograph is and will remain the principal diagnostic tool for inflammatory lung disease, with the gallium-67 scan serving as a complementary study.
• Limitations the authors state:
  • The scanning system's limited resolution restricts detection of lesions before they are visible on radiographs.
  • Using gallium scans to decide which lung cancer patients need mediastinoscopy was described as still debatable, needing more data from prospective protocols.

Topics

Medical terms in this study, explained in our Lexicon: Chest X-Ray, Interstitial, Neoplasm, Staging, Lung Cancer, Mediastinoscopy.

Related studies

• Multiplane gallium tomography in assessment of occupational chest diseases — E.M. Cordasco, J. O'Donnell, et al. (1990)
• Unexpected gallium uptake in benign pulmonary pathology. Report of two cases — R.G. McLean, D. Choy, et al. (1984)
• Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep — R. Bégin, A. Cantin, et al. (1983)
• Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure — G.L. Delclos, D.G. Flitcraft, et al. (1989)
• Gallium scanning in peritoneal mesothelioma — R.R. Armas, S.J. Goldsmith (1985)
• Gallium scanning in differentiating malignant from benign asbestos-related pleural disease — A.S. Teirstein, P. Chahinian, et al. (1986)

Browse return to medical research.